PET assisted with the tau tracer [18F]PM-PBB3 has been shown to detect different patterns in patients with PSP and CBD compared to AD, indicating a role in differential diagnosis [9]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.